128 results on '"Kovrigina, Alla M."'
Search Results
2. Pathomorphological and clinical characteristics of blastic plasmocytoid dendritic cell neoplasm. Case report
3. Efficacy of brentuximab vedotin in patients with CD30-positive lymphoproliferative skin diseases: results of the first prospective study in the Russian Federation
4. Modern possibilities of therapy for primary cutaneous T-cell lymphomas: the first results of the use of brentuximab vedotin in the Russian Federation
5. А New Combination of Prognostic Markers in Follicular Lymphoma That Influences the Choice of Therapy
6. Repeated haploidentical allogeneic hematopoietic stem cell transplantation with TCR αβ/CD19 depletion in patient with primary myelofibrosis. Case report
7. Multiple primary tumor of hematopoietic tissue: myeloid sarcoma in combination with mantle cell lymphoma. Case report
8. A case report of familial dyskeratosis congenital. Case report
9. Thrombosis in patients with myeloproliferative neoplasms. Case report
10. Modern approaches in the first line treatment of CD30-positive peripheral T-cell lymphomas
11. Low JAK2 V617F Allele Burden in Ph-Negative Chronic Myeloproliferative Neoplasms Is Associated with Additional CALR or MPL Gene Mutations
12. Multiple myeloma
13. Clinicopathologic Predictors of Reversibility Dialysis Dependent Acute Kidney Injury in Patients with Myeloma Cast Nephropathy
14. Diagnostic significance of flow cytometry scales in diagnostics of myelodysplastic syndromes
15. New opportunities of systemic therapy of CD30-positive primary cutaneous T-cell lymphomas
16. Follicular lymphoma
17. Hairy cell leukemia. Clinical recommendations
18. IgG4-associated disease in differential diagnosis of inflammatory orbitopathy
19. R-m-NHL-BFM-90/R-EPOCH Protocol in the Treatment of Patients with Primary Mediastinal Lymphoma: First Results
20. The Frequency of Calr and MPL Gene Mutations in Jak2 V617F - Positive Chronic Myeloproliferative Neoplasms in Russia
21. Diagnostic significance of flow cytometry scales in diagnostics of myelodysplastic syndromes.
22. A Successful Experience with Brentuximab Vedotin in Relapsing/Refractory Cutaneous T-Cell Lymphoma: Two Case Reports
23. The First Experience of Treatment of Patients with Primary Mediastinal Lymphoma Using the R-m-NHL-BFM-90/R-EPOCH Protocol
24. Molecular and Biological Characteristics of Tumour Substrate in Patients with Extramedullary Multiple Myeloma
25. Long-Term Follow-up of Primary Bone Diffuse Large B-Cell Lymphoma Treated with m NHL-BFM-90
26. Late Clonal Disorders in Patients with Aplastic Anemia
27. Long-Term Efficacy of the Combined Immunosuppressive Therapy (IST): Cyclosporine with/without Splenectomy - in Patients with Different Forms of Myelodysplastic Syndromes
28. Clinical and Morphological Features of Different Variants Castleman's Disease
29. Multiple Clonal TCR Gene Rearrangements Are Typical in Peripheral T-Cell Lymphoma Not Otherwise Specified
30. MYD88 L265P Mutation Is a Possible Unfavorable Prognostic Factor in Patients with Diffuse B-Cell Lymphoma
31. MYC Protein Expression Correlates with C-MYC Transcriptional Activity in Absence of Gene Rearrangement in Diffuse Large B-Cell Lymphoma
32. Successful Experience of Treatment of Angioimmunoblastic T-Cell Lymphoma By Prolonged Therapy
33. Detection of T-Cell Clonality in Bone Marrow in Peripheral T-Cell Lymphoma, Not Otherwise Specified
34. Diagnosis and Treatment of Polycythemia Vera (PV) in Russian Federation: Single Center Experience
35. A Single Institutional Experience of 49 Patients with Large Granular Lymphocytic Leukemia: Clinical and Immunophenotypic Characteristics and the Significance of Immune Therapy
36. Less Toxic Gemcitabine-Oxaliplatin Based Induction Regimen (R-GIDIOX) Prior to Autologous SCT Produces Outcomes Similar to High-Dose Cytarabine Containing Intensive Induction Regimen in Mantle Cell Lymphoma – a Follow up Report of the Multicenter Study
37. Detection of B-Cell Clonality in Bone Marrow Is Independent Predictor of Outcome in De Novo Diffuse Large B-Cell Lymphoma Patients Treated with High-Dose Chemotherapy
38. Front-Line High Dose Therapy with Following Autologous Stem Cell Transplantation (ASCT) for Follicular Lymphoma Patients
39. B-Cell Lymphoma Unclassified, Intermediate Between Diffuse Large B-Cell Lymphoma and Burkitt Lymphoma: A Single Center Experience of Intensive Chemotherapy with and without Auto-SCT
40. The Role Of Splenectomy In The Treatment Of Myelofibrosis
41. Prognostic Role Of The Microenvironment In Follicular lymphoma
42. Treatment of Primary Bone Lymphoma with Intensive Chemotherapy
43. Blood and Lymphatic Microenvironment As Prognostic Marker in Follicular Lymphoma.
44. Histopathological Features of Bone Marrow and Extramedullary Sites in Patients with Multiple Myeloma
45. Two Variants of Follicular Lymphoma Grade 3
46. Bone Marrow Involvement in Primary Mediastinal B-Cell Large-Cell Lymphoma
47. Theraputic Approaches to High Grade B-Cell Lymphoma Double-Hit and Follicular Lymphoma with C -MYC, BCL2and/or BCL6rearrangements. Single Center Expirience
48. Extramediastinal Lesion in Patients with Primary Mediastinal Large B-Cell Lymphoma
49. Late Events in Adult Patients with ALK-Positive Anaplastic Large Cell Lymphoma
50. Rituximab-Bendamustine in First Line Treatment of Patients with Follicular Lymphoma. Results of Prospective Multicenter Study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.